A pharmacy in Okinawa Prefecture has gone online to ensure residents on remote islands hundreds of kilometers away continue to get their supply of medications. https://www.japantimes.co.jp/news/2026/02/02/japan/society/okinawa-remote-islands-medicines/?utm_medium=Social&utm_source=mastodon #japan #society #okinawa #medicine #pharmaceuticals #internet #sukoyaka
Over-the-counter (OTC) sales of an emergency contraceptive pill, aimed at preventing unwanted pregnancy, are set to start in Japan on Monday. https://www.japantimes.co.jp/news/2026/02/01/japan/science-health/emergency-contraceptive-pills-over-the-counter/?utm_medium=Social&utm_source=mastodon #japan #sciencehealth #pregnancy #drugstores #pharmaceuticals #health
Quixoticgeek
boosted
The regulars at the gym I go to twice a week have noticed no real new year resolution driven surge of new members this year... and we wondered why?
Our best guess was the impact of weight-loss drugs; giving people a different route rather than gym training, to pushing weight loss as a news year commitment.
Not sure if that accounts for all of the absence(s) but it is very noticeable this year compared to others.
The regulars at the gym I go to twice a week have noticed no real new year resolution driven surge of new members this year... and we wondered why?
Our best guess was the impact of weight-loss drugs; giving people a different route rather than gym training, to pushing weight loss as a news year commitment.
Not sure if that accounts for all of the absence(s) but it is very noticeable this year compared to others.
Hisamitsu Pharmaceutical’s ¥457 billion plan to go private is being seen as a prime example of a flight from public markets among Japan’s drugmakers, with analysts expecting more to follow. https://www.japantimes.co.jp/business/2026/01/08/companies/buyout-wave-seen-among-japanese-drugmakers/?utm_medium=Social&utm_source=mastodon #business #companies #hisamitsu #salonpas #pharmaceuticals #acquisitions #stocks #tse #pharmaceuticals #health #medicine
Hisamitsu Pharmaceutical surged the most in more than 47 years after the Japanese maker of pain-relief patches announced it would go private in a management buyout valued at about $2.9 billion. https://www.japantimes.co.jp/business/2026/01/07/markets/hisamitsu-shares-jump-buyout/?utm_medium=Social&utm_source=mastodon #business #markets #hisamitsu #salonpas #pharmaceuticals #acquisitions
Hisamitsu Pharmaceutical’s management is considering a takeover bid to privatize the Japanese maker of pain-relief patches in a deal that could be worth around ¥450 billion ($2.9 billion). https://www.japantimes.co.jp/business/2026/01/06/companies/salonpas-hisamitsu-tob/?utm_medium=Social&utm_source=mastodon #business #companies #hisamitsupharmaceutical #salonpas #pharmaceuticals
✨ Hisamitsu Pharmaceutical: Takeover Bid to Go Private
🔗 https://www.adalta.info/pdf/index.html?title=prstn_patch_115846895533542598&lang=en
[ Verfügbar in 🇩🇪 (lang=de)//Available in 🇺🇸 (lang=en)//Disponible en 🇫🇷 (lang=fr) ]
#Patch #Business #Companies #Hisamitsupharmaceutical #Salonpas #Pharmaceuticals #AISummary #Bot
Hisamitsu Pharmaceutical’s management is considering a takeover bid to privatize the Japanese maker of pain-relief patches in a deal that could be worth around ¥450 billion ($2.9 billion). https://www.japantimes.co.jp/business/2026/01/06/companies/salonpas-hisamitsu-tob/?utm_medium=Social&utm_source=mastodon #business #companies #hisamitsupharmaceutical #salonpas #pharmaceuticals
Lisa Melton
boosted
"Trump claimed drug companies would be forced to give Americans the lowest prices in the world. ...
Now reality has arrived. And it brought the receipts.
As of yesterday, drugmakers are raising U.S. prices on at least 350 branded medications—up sharply from 250 last year."
~ Michael Cohen
"Trump claimed drug companies would be forced to give Americans the lowest prices in the world. ...
Now reality has arrived. And it brought the receipts.
As of yesterday, drugmakers are raising U.S. prices on at least 350 branded medications—up sharply from 250 last year."
~ Michael Cohen
Drugmakers raise US prices on 350 medicines despite pressure
#HackerNews #DrugPrices #Healthcare #Pharmaceuticals #Medicine #PriceIncrease
Alzheimer's trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite their failure, underscore a shift to approaching the brain-wasting disease as a system of complex pathways. https://www.japantimes.co.jp/news/2025/12/12/world/science-health/alzheimers-trials-shift-approach/?utm_medium=Social&utm_source=mastodon #worldnews #sciencehealth #aging #dementia #alzheimer039s #pharmaceuticals #medicine #eisai #novonordisk
Cory Doctorow
and 1 other
boosted
So the UK has agreed to raise the price it pays for US-supplied medicines as part of a deal to avoid tariffs on UK pharmaceutical exports to the USA.... but the Treasury is not allowing for this price rise in its NHS budgetary settlement.
So, its one more mechanism to transfer NHS spending to the private sector while worsening the budget pressures on the health service.
Resident Doctors might also ask: if you can find £1.5bn for this, where's our money?
#NHS #pharmaceuticals #politics
h/t FT
So the UK has agreed to raise the price it pays for US-supplied medicines as part of a deal to avoid tariffs on UK pharmaceutical exports to the USA.... but the Treasury is not allowing for this price rise in its NHS budgetary settlement.
So, its one more mechanism to transfer NHS spending to the private sector while worsening the budget pressures on the health service.
Resident Doctors might also ask: if you can find £1.5bn for this, where's our money?
#NHS #pharmaceuticals #politics
h/t FT
Chinese vaccine makers are caught in a steep downturn as intensifying competition pushes prices lower and erodes their profits. https://www.japantimes.co.jp/business/2025/12/02/companies/china-flu-shots-vaccine-makers/?utm_medium=Social&utm_source=mastodon #business #companies #pharmaceuticals #china #drugmakers #covid19vaccines #vaccinations
The U.S. faces a growing national security risk due to heavy dependence on China for key pharmaceutical ingredients, prompting calls to diversify supply chains to reduce vulnerability to geopolitical or health crises. https://www.japantimes.co.jp/commentary/2025/11/30/world/china-global-pharmaceuticals-card/?utm_medium=Social&utm_source=mastodon #commentary #worldnews #china #drugs #medicine #supplychains #us #pharmaceuticals
Japan will soon begin full-fledged discussions on revising medical service fees as inflation hits profits of clinics and hospitals. https://www.japantimes.co.jp/news/2025/11/29/japan/science-health/medical-service-fees-discussion/?utm_medium=Social&utm_source=mastodon #japan #sciencehealth #health #pharmaceuticals #japanmedicalassociation #medicine #financeministry
Scientists are still asking if GLP-1 drugs should be tested to prevent Alzheimer's in people at risk. https://www.japantimes.co.jp/business/2025/11/26/companies/novo-nordisk-glp-1-alzheimers/?utm_medium=Social&utm_source=mastodon #business #companies #novonordisk #alzheimer039s #pharmaceuticals
Indian officials are investigating whether safety lapses in the supply of a pharmaceutical ingredient were responsible for contaminating cough syrup that has killed at least 24 children. https://www.japantimes.co.jp/news/2025/11/24/asia-pacific/crime-legal/indian-probe-children-cough-syrup/?utm_medium=Social&utm_source=mastodon #asiapacific #crimelegal #india #pharmaceuticals